US1569441009
US1569441009
CG Oncology, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 4.040.000 | 1.139.000 | 254.7% |
| Cost of Revenue | 4.647.000 | -- | -- |
| Gross Profit | -607.000 | 1.139.000 | 153.3% |
| 190.167.000 | 115.805.000 | 64.2% | |
| Operating Income | -190.774.000 | -114.666.000 | 66.4% |
| Pretax Income | -160.995.000 | -88.039.000 | 82.9% |
| Net Income Common Stockholders | -160.995.000 | -88.039.000 | 82.9% |
| -- | -- | -- | |
| -- | -- | -- |